Social Responsibility

At Myriad, corporate responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives. We believe that our social responsibility programs:

  • Build greater value for our patients, healthcare professionals and shareholders;
  • Support and improve the communities where we live and work; and
  • Empower our employees to become more engaged in the well-being of their own communities.

The social responsibility programs at Myriad align with a clearly-defined set of strategic priorities including:

  • Philanthropy Myriad provides financial support to nonprofit organizations and shares the expertise of Myriad employees in the communities where we operate.
  • Advocacy Myriad collaborates with and supports key patient advocacy and support organizations where we have the ability to make a positive difference in addressing complex health challenges, providing education about diagnostic testing and improving the quality of life for patients.
  • Scholarship Myriad provides financial support for academic scholarship and education at both the undergraduate and post-graduate levels, and contributes to advancing education and training for women and minorities in medicine and science.
  • Patient Assistance Myriad is working to improve overall healthcare quality and increase access to diagnostic testing for uninsured and underinsured populations by offering robust financial assistance and free testing to those in need.

Environmental, Social, and Governance at Myriad

“For more than 31 years, Myriad Genetics has worked to be a force for good in the world as we fulfill our mission of health and well-being for all. In our inaugural ESG report, we seek to convey our core values as a caring, ethical, and sustainable company committed to continuous improvement,” said Paul J. Diaz, president and CEO, Myriad Genetics. “We are committed to intensifying our ESG focus helping to address the needs of the patients, healthcare providers, stakeholders, and communities we serve.”

Data-sharing, discovery and insights

Data-driven insights are vital to advancing scientific innovation and improving health outcomes. Patients and providers are at the center of our mission to make genetic testing and data-driven medical information more widely available. Myriad Genetics maintains close relationships with healthcare providers and health systems, academic centers, government agencies, and other collaborators to maintain the integrity and security of shared data for use in clinical care and scientific research.

  • Beginning in Spring 2023, we will share clinically impactful hereditary cancer and prenatal data submissions with the ClinVar public database. ClinVar is operated by the National Center for Biotechnology Information (NCBI), part of the National Institutes of Health (NIH), to help aggregate information about genomic variation and its relationship to public health. We will continue to submit prenatal germline variants to ClinVar, consistent with our already established practice. For our oncology products, we will immediately focus on sharing more recently identified or reclassified pathogenic/likely pathogenic germline sequencing variants, as they are the most clinically impactful.
  • With our new suite of Precise Oncology Solutions, Myriad launched the Precise Treatment Registry available to all healthcare providers to help advance equitable patient care and accelerate the pace of precision cancer research. It combines targeted tumor, germline and homologous recombination deficiency (HRD) genetic data, allowing physicians to access clinical insights on key patient populations. The registry enables clinicians to explore hypotheses in real time by analyzing diverse de-identified patient data involving ancestry, geography, cancer diagnosis, treatment outcomes and more. Open to all healthcare providers who register, the Precise™ Treatment Registry is powered by DNAnexus’ secure cloud bioinformatics platform for scientific data analysis, collaboration and discovery.
  • We contribute hereditary cancer data to the California and Georgia SEER registries, funded by the National Cancer Institute. The registries collect and publish cancer incidence, prevalence, and survival data.
  • We share our expertise and classification advancements through more than 1,000 scientific publications to date, including specific variant classifications in addition to internal approaches to variant classifications and reclassifications. These studies are conducted in partnership with leading industry collaborators and are regularly published in peer-reviewed journals such as the Journal of the American Medical Association, Psychiatry Research, Annals of Oncology, Cancer Genetics, JCO Precision Oncology and others.
  • Myriad Genetics has a lifetime commitment to provide patients who have received hereditary cancer test results with timely, up-to-date information on their gene variants. Through our work, we are learning more about genetics every day – some of which has a material impact on the millions of patients who have undergone our testing in the past.
  • We share data and classifications relevant to specific medical requests. We also share data and research at major medical association meetings and industry conferences.

We value the trust patients and healthcare providers have placed in us. We continue to identify ways to further leverage our datasets as part of our mission to improve health and well-being for all, and enable healthcare providers to better detect, treat and prevent disease.

Myriad Advocacy

Myriad is proud to sponsor and partner with disease advocacy and patient support groups who provide education, awareness and resources to cancer survivors, previvors, caregivers and others affected by cancer or other major diseases.

Myriad has collaborated on projects with advocacy groups, support groups and survivor networks, including:

Myriad Scholarships

Each year, Myriad provides scholarships to college science majors because we believe that supporting today’s aspiring young leaders is a great investment in the future. Here is what recent scholarship recipients had to say:

“Because of your generosity in donating to the College of Science, I will be able to continue to devote myself to my studies while maintaining active involvement in extracurricular activities such as community service, healthcare professional shadowing and research, all of which have certainly enhanced my experience at the University of Utah.” – Bryn E. McNerny

“Thank you very much for being the big local company that is willing to invest in a local scientist with big dreams.” – Zachary Lee

“This scholarship will provide me with great motivation to continue pursing science and learn everything possible during the process.” – Donghwi Bae

“This grant will be a significant help in my future studies.  As a first-generation college student living along with my mother, a Ukrainian immigrant, financial support from my family is minimal.” – Elena Nazarenko

“Words cannot express how thankful I am for receiving this annual scholarship; and my parents could not be more proud.  We are all so overjoyed with happiness.” – Boya Li

Latest news

honoring-those-affected-by-rare-diseases Thumbnail

Honoring those affected by rare diseases

Quick — name three diseases that affect humans. We bet you came up with some of the most well-known, such as heart disease, cancer, Alzheimer’s, and COVID-19. Those are all extremely common, affe...

Read more